Terumo Blood and Cell Technologies is a global leader in medical technology, specializing in blood component collection, therapeutic apheresis, and cellular therapy technologies that impact patients' lives every second of every day. With more than 8,000 global associates and operations spanning 130+ countries, the company's innovative solutions enable healthcare providers to deliver life-saving treatments worldwide. Their products process blood components safely, treat serious medical conditions through therapeutic plasma exchange, and advance cellular therapy manufacturing - all while maintaining a patient-centered approach that drives measurable results across their core business areas.
Headquartered in Lakewood, Colorado, Terumo BCT operates as part of Terumo Corporation (TSE:4543), a Tokyo-based global healthcare leader founded in 1921. The company's commitment extends beyond technology to include partnerships with organizations like The Leukemia & Lymphoma Society, comprehensive blood safety initiatives, and the 'From the Heart' global program designed to educate and empower communities. Through platforms like Quantum Flex Cell Expansion System for CAR-T therapies and Spectra Optia Apheresis System for treating conditions like sickle cell disease, Terumo BCT continues to expand access to critical treatments and shape the future of blood and cell-based therapies.
